Live Breaking News & Updates on Expands Clinical Trial Sites

Stay updated with breaking news from Expands clinical trial sites. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Genprex Expands Clinical Trial Sites for Acclaim-3 Clinical Study of Reqorsa® Therapy in Combination with Tecentriq® to Treat Small Cell Lung Cancer

Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that through its collaboration agreement with a. ....

United States , Genentech Tecentriq , Mark Berger , Kalyn Dabbs , Rodney Varner , Exchange Commission , Drug Administration , Genprex Inc , Prnewswire Genprex Inc , Company Website , Expands Clinical Trial Sites , Treat Small Cell Lung , Fast Track , Immunogene Therapy , Chief Executive Officer , Chief Medical Officer , Maximum Tolerated Dose , Recommended Phase , Ophran Drug , Delivery System , Fast Track Designation , Private Securities Litigation Reform Act , Annual Report , Nasdaq Capital Market ,